Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Enanta Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ENTA
Nasdaq
2834
https://www.enanta.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
- Apr 17th, 2024 11:00 am
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
- Mar 6th, 2024 12:00 pm
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
- Feb 12th, 2024 11:15 am
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
- Feb 8th, 2024 2:07 pm
Q1 2024 Enanta Pharmaceuticals Inc Earnings Call
- Feb 8th, 2024 12:08 pm
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
- Feb 7th, 2024 10:10 pm
Enanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q1 2024 Results: Royalty Revenue Declines Amid ...
- Feb 7th, 2024 9:59 pm
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
- Feb 7th, 2024 9:01 pm
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 6th, 2024 12:00 pm
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
- Jan 31st, 2024 12:00 pm
Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?
- Jan 5th, 2024 8:09 am
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 4th, 2024 12:00 pm
Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 12:00 pm
The Zacks Analyst Blog Highlights Enanta, OneConnect Financial, KNOT Offshore, Hippo Holdings and H World
- Dec 20th, 2023 11:00 am
Insider Sell Alert: Director Terry Vance Sells 15,295 Shares of Enanta Pharmaceuticals Inc (ENTA)
- Dec 16th, 2023 10:01 am
Wall Street Analysts Predict a 108.12% Upside in Enanta Pharmaceuticals (ENTA): Here's What You Should Know
- Dec 13th, 2023 2:55 pm
How Much Upside is Left in Enanta Pharmaceuticals (ENTA)? Wall Street Analysts Think 88.23%
- Nov 27th, 2023 2:55 pm
Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
- Nov 22nd, 2023 12:00 pm
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2023 Earnings Call Transcript
- Nov 21st, 2023 1:46 pm
Q4 2023 Enanta Pharmaceuticals Inc Earnings Call
- Nov 21st, 2023 12:18 pm
Scroll